Morphic Holding had a nice pop today and is currently up 4.14% we'll see if the cash keeps flowing in.
It looks like Morphic Holding isn't currently at a very decisive point in regards to support/resistance levels. Momentum wise Morphic Holding, has been oscillating up and down but hasn't shown much directional energy that would be predictive to the near future. MORF might find some support at the 20.71 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts feel fairly neutral on the prospects for Morphic Holding but a little more positive than negative. The current Analysts Sentiment Score is 16.24. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Citigroup initiated a rating of Buy on 2023-12-08 and provided a price target of $46.00. Leerink Partnrs reiterated a rating of Outperform on 2023-10-16. BMO Capital Markets provided a price target decease of -50.94% to $52.00 from $106.00 on 2023-09-28. On 2023-09-25 there was a downgrade announced by BTIG Research from Buy to Neutral. On 2023-09-25 Stifel Nicolaus lowered their price target by -45.9% to $33.00. On 2023-07-21 Berenberg Bank started covering Morphic Holding with a rating of Buy and they set their price target at $75.00.Royal Bank of Canada gave a boost to their price target and moved to $80.00 from $75.00 on 2023-04-26. Wells Fargo & Company boosted their price targ by 19.4% to $80.00 on 2023-04-25. SVB Securities gave a boost to their price target and moved to $56.00 from $45.00 on 2023-03-08. SVB Leerink boosted their price targ by 24.44% to $56.00 on 2023-03-08.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| MORF | 16.24 | 34.09 | -8.46 | 23.55 | -16.69 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| MORF | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| MORF | 11.22 | %11.3314 | 5.2 | 47.982 | 5430000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| MORF |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INSM | Insmed, Inc. | 0.9 | -0.43 | 2.20 | -9.11 | -10.57 | 2.16 | 30.62 | 31 | 7.28 | 9.35 | 44.47 | -3030.47 | -14664.07 | 0 | 0 | 9.8069 |
| EDIT | Editas Medicine, Inc. Com | 0.9 | 0.89 | 5.59 | -15.62 | -20.92 | -19.35 | -34.98 | 26 | 1.11 | -0.78 | -6.75 | -18653.05 | -1877.60 | 0 | 100 | 16.4101 |
| RCKT | Rocket Pharmaceuticals, I | 0.89 | 3.07 | 7.41 | -3.77 | -19.79 | 22.18 | 25.58 | 38 | 12.18 | 32.42 | 36.89 | -2746.04 | -17665.95 | 0 | 0 | 9.12889 |
| XNCR | Xencor, Inc. | 0.86 | 2.03 | 14.43 | 12.14 | 29.28 | 37.85 | -12.77 | 41 | 4.75 | 5.27 | 1.01 | -10748.00 | -2169.32 | 0 | 0 | 15.4823 |
| FATE | Fate Therapeutics, Inc. | 0.86 | -0.98 | 0.50 | -39.49 | -33.55 | 83.71 | -34.20 | 42 | 190.86 | 48.02 | 32.47 | -27079.19 | -7042.22 | 0 | 0 | 7.69285 |
| FOLD | Amicus Therapeutics, Inc | 0.82 | -0.29 | 1.46 | -10.34 | -21.98 | -4.85 | -12.24 | 11 | 2.74 | 6.82 | 14.65 | -9256.84 | -1705.64 | 0 | 0 | 9.67196 |
| SAGE | Sage Therapeutics, Inc | 0.82 | 6.37 | -1.69 | -16.02 | -41.38 | -28.73 | -71.02 | 27 | -22.06 | -22.77 | -15.93 | -51237.60 | -1298.12 | 0 | 0 | 12.6533 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
